Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide is feasible in bone marrow transplantation for osteopetrosis.

Authors	Rahul Naithani
Journal	Pediatric transplantation (Pediatr Transplant) Vol. 19 Issue 7 Pg. 801-2 (Nov 2015) ISSN: 1399-3046 [Electronic] Denmark
PMID	26179773 (Publication Type: Letter, Comment)
Chemical References	Cyclophosphamide Busulfan
Topics	Busulfan (administration & dosage) Cyclophosphamide (administration & dosage) Female Hematopoietic Stem Cell Transplantation Humans Male Osteopetrosis (therapy) Transplantation Conditioning (methods) Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!